Skip to main content

Verition Fund Management LLC

Position in LNTH — Lantheus Holdings, Inc.

CIK 1454027 GREENWICH, CT

Position in LNTH

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,551,000
-$1,272,125 QoQ
Shares Held
60,000
-31.4% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
11 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in LNTH Over Time

Shares Held

Position Value (USD)

Derivatives in LNTH

reported options exposure · as of Dec 31, 2023
CallValue
$1,184,200
CallShares
19,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Verition Fund Management LLC holds $14,533,555 across 10 Drug Manufacturers - Specialty & Generic names. LNTH ranks #2 (31.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 LNTH
Lantheus Holdings, Inc.
This page
60,000 $4,551,000

All Filings in LNTH

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,551,000 60,000
2025-12-31 $5,823,125 87,500
2025-09-30 $8,358,731 162,970
2025-06-30 $2,569,176 31,385
2024-06-30 $631,159 7,861
2024-03-31 $708,228 11,379
2023-12-31 $1,184,200 19,100
2023-06-30 $393,500 4,689
2022-12-31 $738,206 14,486
2022-09-30 $725,453 10,315
2022-06-30 $472,972 7,163